Jean-Pierre Mach
9Patents
4h-index
27Co-inventors
57Inventor score
Filing activity: Jan 4, 1989 → Aug 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5047507A | Monoclonal antibodies with specificity affinity for human carcinoembryonic antigen | Human Necessities | 53 | Expired |
| US9809654B2 | Targeted CD1d molecules | Chemistry; Metallurgy | 8 | Active |
| US9603922B2 | Modulation of NKT cell activity with antigen-loaded CD1d molecules | Chemistry; Metallurgy | 8 | Active |
| US5672513A | Carcino-embryonic antigen derivatives lacking the carboxyl terminal end | Emerging Cross-Sectional Technologies | 4 | Expired |
| US10815310B2 | Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains | Chemistry; Metallurgy | 3 | Active |
| US9631031B2 | Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains | Chemistry; Metallurgy | 3 | Active |
| US12378325B2 | Multispecific antigens binding fragments and multspecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US11945879B2 | Multispecific antigens binding fragments and multispecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US7968103B2 | Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.